Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.3.8399.9419
Address
Level 3, Suite 69 574 Plummer Street Port Park-Building 2 Port Melbourne, Victoria (VIC) 3207
Description
Wellnex Life Ltd. engages in the provision of health and wellness products. It specializes in licensing and taking brands to the market in Australia and Asia. The company was founded by Lazarus Karasavvidis and Martin Glenister on May 6, 2011 and is headquartered in Port Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.02 - 0.04
Trade Value (12mth)
AU$6,668.00
1 week
-6.45%
1 month
20.83%
YTD
11.54%
1 year
-27.86%
All time high
2.01
EPS 3 yr Growth
-87.700%
EBITDA Margin
-28.30%
Operating Cashflow
-$6m
Free Cash Flow Return
-119.10%
ROIC
-266.50%
Interest Coverage
-4.70
Quick Ratio
0.40
Shares on Issue (Fully Dilluted)
506m
HALO Sector
Staples
Next Company Report Date
30-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
24 July 24 |
Wellnex Raises $2m Placement and Update on LSE Dual Listing
×
Wellnex Raises $2m Placement and Update on LSE Dual Listing |
24 July 24 |
Proposed issue of securities - WNX
×
Proposed issue of securities - WNX |
24 July 24 |
Application for quotation of securities - WNX
×
Application for quotation of securities - WNX |
22 July 24 |
Trading Halt
×
Trading Halt |
09 July 24 |
Investor Presentation
×
Investor Presentation |
03 July 24 |
Application for quotation of securities - WNX
×
Application for quotation of securities - WNX |
02 July 24 |
Notification of cessation of securities - WNX
×
Notification of cessation of securities - WNX |
01 July 24 |
Trading Update - June
×
Trading Update - June |
28 June 24 |
Extension of Cleansing Prospectus Offer Period
×
Extension of Cleansing Prospectus Offer Period |
28 June 24 |
Resignation of Chair
×
Resignation of Chair |
28 June 24 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
13 June 24 |
Trading Update - May
×
Trading Update - May |
05 June 24 |
Wellnex Launches Medicinal Cannabis Brand Wellness Life
×
Wellnex Launches Medicinal Cannabis Brand Wellness Life |
31 May 24 |
Extension of Cleansing Prospectus Offer Period
×
Extension of Cleansing Prospectus Offer Period |
31 May 24 |
Application for quotation of securities - WNX
×
Application for quotation of securities - WNX |
28 May 24 |
Release From Voluntary Escrow
×
Release From Voluntary Escrow |
24 May 24 |
Wellnex Re-engages CW NZ and Supplies First Pain Away Order
×
Wellnex Re-engages CW NZ and Supplies First Pain Away Order |
09 May 24 |
Business Update
×
Business Update |
08 May 24 |
Launch of Additional Wakey Wakey Products
×
Launch of Additional Wakey Wakey Products |
03 May 24 |
Extension of Cleansing Prospectus Offer Period
×
Extension of Cleansing Prospectus Offer Period |
03 May 24 |
Application for quotation of securities - WNX
×
Application for quotation of securities - WNX |
30 April 24 |
Appendix 4C and Quarterly Report for Mar 2024 Quarter
×
Appendix 4C and Quarterly Report for Mar 2024 Quarter |
23 April 24 |
Wellnex to Dual List on the London Stock Exchange
×
Wellnex to Dual List on the London Stock Exchange |
23 April 24 |
Chairman's Letter
×
Chairman's Letter |
19 March 24 |
Notification regarding unquoted securities - WNX
×
Notification regarding unquoted securities - WNX |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.